Milestone Pharmaceuticals Inc. (MIST) Major Shareholder Buys $4,999,995.00 in Stock

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) major shareholder Holdings A/S Novo acquired 333,333 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were bought at an average price of $15.00 per share, for a total transaction of $4,999,995.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

NASDAQ:MIST opened at $19.01 on Friday. Milestone Pharmaceuticals Inc. has a 52-week low of $15.09 and a 52-week high of $19.09.

ILLEGAL ACTIVITY WARNING: “Milestone Pharmaceuticals Inc. (MIST) Major Shareholder Buys $4,999,995.00 in Stock” was first published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/05/17/milestone-pharmaceuticals-inc-mist-major-shareholder-buys-4999995-00-in-stock.html.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc, a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina.

Further Reading: What are Bollinger Bands?

Receive News & Ratings for Milestone Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.